Publication
TGA shelves biosimilar and generic transparency measures
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Adminis...
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
© Norton Rose Fulbright LLP 2023